Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-16

Clinical Trial Update: Ginkgo Biloba Prevention Trial in Older Individuals [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating Ginkgo Biloba for prevention of dementia in older individuals has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo biloba (Ginkgo biloba)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Dementia, Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-09-16